HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Outcome of duodenopancreatic resections in patients with multiple endocrine neoplasia type 1.

AbstractOBJECTIVE:
To evaluate the outcome of an aggressive surgical approach for duodenopancreatic neuroendocrine tumors (PETs) associated with multiple endocrine neoplasia type 1 (MEN1).
SUMMARY BACKGROUND DATA:
The management of PETs is still controversial in the setting of the autosomal dominant inherited MEN1 syndrome.
METHODS:
MEN1 patients that had either biochemical evidence of functioning PETs or visualized nonfunctioning PETs larger than 1 cm in size on imaging were operated. Since 1997, patients were followed annually by biochemical testing and imaging studies.
RESULTS:
Twenty-six genetically confirmed MEN1 patients underwent duodenopancreatic resection for functioning (n = 17) or nonfunctioning (n = 9) PETs. Ten (38%) patients had malignant PETs as characterized by the presence of lymph node (10 patients) and/or distant metastases (2 patients). The surgical approach was selected based on the type, location, and size of PETs. Four Zollinger-Ellison syndrome (ZES) patients required pylorus preserving pancreaticoduodenectomy (PPPD) as initial or redo procedure, 20 patients underwent other duodenopancreatic resections, and 2 patients had simple enucleations of PETs. After median 83 months (range, 5-241 months), 24 patients were alive and 2 patients died of an unrelated cause. All patients with insulinoma or vipoma and 7 of 11 patients with ZES were biochemically cured, including the ZES patients who underwent PPPD. However, 19 of 26 (73%) patients developed new small PETs (<1 cm) in the pancreatic remnant, but no patient had yet detectable metastases on imaging.
CONCLUSIONS:
Early and aggressive surgery of PETs in MEN1 patients prevents the development of liver metastases, which are the most life-threatening determinant. PPPD might be the procedure of choice for MEN1-ZES, which has to be proven in large scale studies.
AuthorsDetlef K Bartsch, Volker Fendrich, Peter Langer, Ilhan Celik, Peter H Kann, Matthias Rothmund
JournalAnnals of surgery (Ann Surg) Vol. 242 Issue 6 Pg. 757-64, discussion 764-6 (Dec 2005) ISSN: 0003-4932 [Print] United States
PMID16327485 (Publication Type: Journal Article)
Topics
  • Adolescent
  • Adult
  • Aged
  • Chi-Square Distribution
  • DNA Mutational Analysis
  • Female
  • Gastrinoma (pathology, surgery)
  • Humans
  • Insulinoma (pathology, surgery)
  • Lymphatic Metastasis
  • Male
  • Middle Aged
  • Multiple Endocrine Neoplasia Type 1 (genetics, pathology, surgery)
  • Neoplasm Recurrence, Local
  • Pancreatic Neoplasms (genetics, pathology, surgery)
  • Pancreaticoduodenectomy (methods)
  • Postoperative Complications
  • Prospective Studies
  • Statistics, Nonparametric
  • Treatment Outcome
  • Vipoma (pathology, surgery)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: